Author
Inserm
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
4 papers
Recent·Most cited
Frédéric Larbret, Marie Irondelle, Sophie Tartare‐Deckert, Marcel Deckert
The paper develops CytoFRET2 to monitor cytoskeletal dynamics and identifies KAT inhibitors as modulators of vimentin assembly.
Margaux Lecacheur, Ilona Berestjuk, Alexandrine Carminati…·Sophie Tartare‐Deckert
This study shows that ECM stiffness influences dedifferentiated melanoma cells via DDR1/2 and YAP, affecting their behavior and drug resistance.
Michael Ohanna, Pierric Biber, Mira Kahil…·Marcel Deckert
This study identifies PSMD14 as a key driver of melanoma survival and resistance to MAPK inhibitors by deubiquitinating histone H2A, altering chromatin state and gene expression.
Ana Carolina Bastos Sant'Anna Silva, Patricia Abbe, Sophie Pagnotta…·Stéphane Rocchi
This study identifies MELK as a key driver of metabolic adaptation and therapy resistance in melanoma, showing that inhibiting MELK can sensitize resistant cells to immunotherapy.